Literature DB >> 348093

Outbreak of multiply drug-resistant Proteus mirabilis originating in a surgical intensive care unit: in vitro susceptibility pattern.

T T Yoshikawa, S A Shibata, A W Chow, L B Guze.   

Abstract

A multiply drug-resistant strain of Proteus mirabilis was isolated from 14 patients on a surgical service. Antimicrobial susceptibility studies demonstrated that the organism was highly resistant to numerous antibiotics, including gentamicin, tobramycin, and sisomicin. The organism was susceptible in vitro to amikacin but had low-level resistance to netilmicin. In vitro susceptibility studies with combinations of cephalothin with netilmicin and trimethoprim with sulfamethoxazole showed these drugs to be synergistic. Other drug combinations failed to act synergistically.

Entities:  

Mesh:

Year:  1978        PMID: 348093      PMCID: PMC352209          DOI: 10.1128/AAC.13.2.177

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Clinical pharmacology of amikacin and kanamycin.

Authors:  W M Kirby; J T Clarke; R D Libke; C Regamey
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

2.  Synergism of cefazolin-gentamicin against enterococci.

Authors:  M Bourque; R Quintiliani; R C Tilton
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

3.  In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.

Authors:  H Knothe
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

4.  In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.

Authors:  R D Meyer; L L Draus; K A Pasieczinik
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

5.  Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.

Authors:  J F Acar; J L Witchitz; F Goldstein; J N Talbot; F Le Goffic
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

6.  In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.

Authors:  V Dhawan; E Marso; W J Martin; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

7.  Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.

Authors:  B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  In vitro activity of netilmicin, gentamicin, and amikacin.

Authors:  R J Kantor; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

9.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

10.  Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.

Authors:  K E Price; M D DeFuria; T A Pursiano
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

View more
  2 in total

1.  Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis.

Authors:  Ahmed Esmael; Sabah A Abo-Elmaaty; Esraa M Khafaga; Soheir Abdelrahman; Mervat G Hassan
Journal:  Arch Virol       Date:  2021-09-24       Impact factor: 2.574

2.  Typing of Proteus mirabilis by bacteriocin production and sensitivity as a possible epidemiological marker.

Authors:  J W Kusek; L G Herman
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.